• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阳性淋巴结比率作为胃癌患者的预后因素:它是否会在指南中取代阳性淋巴结数量?

Positive lymph node ratio as a prognostic factor for gastric cancer patients: Is it going to supersede positive lymph node number in guidelines?

机构信息

Department of General Surgery, Acibadem Mehmet Ali Aydinlar University, School of Medicine, Istanbul, Turkey.

Department of General Surgery, Sisli Hamidiye Etfal Education and Research Hospital, Istanbul, Turkey.

出版信息

Medicine (Baltimore). 2023 May 19;102(20):e33757. doi: 10.1097/MD.0000000000033757.

DOI:10.1097/MD.0000000000033757
PMID:37335735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10194709/
Abstract

Gastric malignancies constitute the sixth most common cancer with regards to incidence and have the fifth most mortality rates. Extended lymph-node dissection is the surgical modality of choice while treating advanced stage gastric cancer. It is yet a topic of debate, whether or not the amount of positive lymph nodes after a pathological examination following the surgical intervention is of prognostic value. In this study, it is aimed to evaluate the prognostic significance of positive lymph nodes following the surgery. A total of 193 patients who underwent curative gastrectomy between January 2011 and December 2015 have been considered for a retrospective data collection. The cases with R1-R2 resections, palliative or emergent surgeries are excluded. Metastatic to total number of lymph nodes, corresponded a ratio which was analyzed in this survey and practiced as a predictive parameter of disease outcome. This survey includes 138 male (71.5%) and 55 female (28.5%) patients treated between 2011 and 2015 in our clinic. The survey follow-up duration of the cases range between 0, 2, and 72 months, corresponding an average of 23.24 ± 16.99 months. We calculated cutoff value of 0.09 with, sensitivity is 76.32% for positive to total number of lymph nodes ratio, whereas specivity applies for 64.10%, positive predictive value for 58% and negative predictive value for 80.6%. Positive lymph node ratio has a prognostic value in terms of predicting the prognosis of the patients with gastric adenocarcinoma following a curative gastrectomy. This might in long term contribute to the prognostic analysis of patients if integrated in the current staging system.

摘要

胃恶性肿瘤的发病率居第六位,死亡率居第五位。在治疗进展期胃癌时,扩大淋巴结清扫是首选的手术方式。手术后病理检查阳性淋巴结数量是否具有预后价值仍存在争议。本研究旨在评估手术后阳性淋巴结的预后意义。共纳入 193 例 2011 年 1 月至 2015 年 12 月期间接受根治性胃切除术的患者,进行回顾性数据收集。排除 R1-R2 切除、姑息性或急诊手术的病例。将转移至淋巴结总数的比例作为预测疾病结局的参数进行分析。本研究包括 138 例男性(71.5%)和 55 例女性(28.5%)患者,均在我院接受治疗。病例的随访时间为 0、2 和 72 个月,平均为 23.24±16.99 个月。我们计算出阳性与淋巴结总数比值的截断值为 0.09,其敏感性为 76.32%,特异性为 64.10%,阳性预测值为 58%,阴性预测值为 80.6%。阳性淋巴结比值对预测接受根治性胃切除术后胃腺癌患者的预后具有一定的预后价值。如果将其纳入当前的分期系统,长期来看可能有助于患者的预后分析。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/272c/10194709/039e9c7ef35b/medi-102-e33757-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/272c/10194709/039e9c7ef35b/medi-102-e33757-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/272c/10194709/039e9c7ef35b/medi-102-e33757-g001.jpg

相似文献

1
Positive lymph node ratio as a prognostic factor for gastric cancer patients: Is it going to supersede positive lymph node number in guidelines?阳性淋巴结比率作为胃癌患者的预后因素:它是否会在指南中取代阳性淋巴结数量?
Medicine (Baltimore). 2023 May 19;102(20):e33757. doi: 10.1097/MD.0000000000033757.
2
Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.无论检查的淋巴结数量多少,淋巴结比率都是可切除(R0)胃癌患者的独立预后因素。
Am J Clin Oncol. 2013 Aug;36(4):325-30. doi: 10.1097/COC.0b013e318246b4e9.
3
Prognostic significance of metastatic lymph nodes ratio in patients with gastric adenocarcinoma after curative gastrectomy.根治性胃切除术后胃腺癌患者转移淋巴结比率的预后意义
Chin Med J (Engl). 2014;127(10):1874-8.
4
Survival benefit of greater number of lymph nodes dissection for advanced node-negative gastric cancer patients following radical gastrectomy.进展期淋巴结阴性胃癌患者根治性胃切除术后增加淋巴结清扫数量的生存获益。
Jpn J Clin Oncol. 2016 Jan;46(1):63-70. doi: 10.1093/jjco/hyv159. Epub 2015 Oct 23.
5
Topographic lymph node staging system shows prognostic superiority compared to the 8th edition of AJCC TNM in gastric cancer. A western monocentric experience.胃癌的拓扑淋巴结分期系统优于第 8 版 AJCC TNM 分期系统,具有更好的预后预测价值。一项西方单中心经验。
Surg Oncol. 2020 Sep;34:223-233. doi: 10.1016/j.suronc.2020.04.022. Epub 2020 May 16.
6
Negative-to-Positive Lymph Node Ratio as an Independent Prognostic Factor for Gastric Adenocarcinoma.负-正淋巴结比值是胃腺癌的独立预后因素。
J Coll Physicians Surg Pak. 2021 Jul;31(7):805-810. doi: 10.29271/jcpsp.2021.07.805.
7
The prognostic value of different node staging systems in patients with ≤15 lymph nodes following surgery for gastric adenocarcinoma.不同淋巴结分期系统对胃腺癌手术后淋巴结≤15枚患者的预后价值。
Acta Chir Belg. 2018 Feb;118(1):1-6. doi: 10.1080/00015458.2017.1346036. Epub 2017 Jul 3.
8
Prognostic value of metastatic lymph node ratio as an additional tool to the TNM stage system in gastric cancer.转移性淋巴结比率作为胃癌TNM分期系统的辅助工具的预后价值。
Eur J Surg Oncol. 2015 Jul;41(7):927-33. doi: 10.1016/j.ejso.2015.03.225. Epub 2015 Apr 3.
9
Metastatic lymph node ratio versus number of metastatic lymph nodes as a prognostic factor in gastric cancer.转移性淋巴结比率与转移性淋巴结数量作为胃癌预后因素的比较。
Eur J Surg Oncol. 2012 Jun;38(6):497-502. doi: 10.1016/j.ejso.2012.01.012. Epub 2012 Mar 23.
10
The Prognostic Effect of Metastatic Lymph Node Ratio in Operated Gastric Cancer Patients.转移性淋巴结比率对接受手术的胃癌患者的预后影响
J Coll Physicians Surg Pak. 2020 Oct;30(10):1035-1040. doi: 10.29271/jcpsp.2020.10.1035.

引用本文的文献

1
Prognostic Significance of Lymph Node Ratio (LNR) in Gastric Cancer in Predicting Postoperative Complications and Survival: A Single-Center Study.淋巴结比率(LNR)在预测胃癌术后并发症及生存中的预后意义:一项单中心研究
Cancers (Basel). 2025 Feb 22;17(5):743. doi: 10.3390/cancers17050743.

本文引用的文献

1
High expression correlates with a poor prognosis and the tumor immune microenvironment in gastric cancer.高表达与胃癌的不良预后及肿瘤免疫微环境相关。
Ann Transl Med. 2022 Sep;10(18):990. doi: 10.21037/atm-22-4325.
2
Prognostic value of lymph node density on cancer staging system for gastric cancer without distal metastasis: a population-based analysis of SEER database.无远处转移胃癌淋巴结密度在癌症分期系统中的预后价值:基于 SEER 数据库的人群分析。
World J Surg Oncol. 2022 Sep 29;20(1):325. doi: 10.1186/s12957-022-02795-9.
3
The Effect of HALP Score on the Prognosis of Gastric Adenocarcinoma.
HALP 评分对胃腺癌预后的影响。
J Coll Physicians Surg Pak. 2022 Sep;32(9):1154-1159. doi: 10.29271/jcpsp.2022.09.1154.
4
Is there a survival difference between older adult and younger adult patients with locally advanced gastric cancer with the same lymph node ratio?老年患者与年轻患者局部进展期胃癌且具有相同淋巴结比率者的生存是否存在差异?
J Geriatr Oncol. 2022 Sep;13(7):962-969. doi: 10.1016/j.jgo.2022.06.006. Epub 2022 Jun 21.
5
Albumin/fibrinogen ratio, a predictor of chemotherapy resistance and prognostic factor for advanced gastric cancer patients following radical gastrectomy.白蛋白/纤维蛋白原比值,预测胃癌根治术后化疗耐药及预后的标志物。
BMC Surg. 2022 May 28;22(1):207. doi: 10.1186/s12893-022-01657-1.
6
Association of multiple tumor markers with newly diagnosed gastric cancer patients: a retrospective study.多种肿瘤标志物与新诊断胃癌患者的相关性:一项回顾性研究。
PeerJ. 2022 May 19;10:e13488. doi: 10.7717/peerj.13488. eCollection 2022.
7
Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol.白蛋白结合型紫杉醇辅助治疗联合 S-1 对比奥沙利铂联合卡培他滨用于 D2 胃切除术后 III 期胃腺癌患者的 III 期多中心、开放标签、随机对照临床试验方案。
BMC Cancer. 2021 Jan 12;21(1):56. doi: 10.1186/s12885-020-07772-7.
8
Gastric cancer: a comprehensive review of current and future treatment strategies.胃癌:当前和未来治疗策略的综合综述。
Cancer Metastasis Rev. 2020 Dec;39(4):1179-1203. doi: 10.1007/s10555-020-09925-3. Epub 2020 Sep 7.
9
Lymph node yield and lymph node density for elective level II-IV neck dissections in laryngeal squamous cell carcinoma patients.喉鳞癌患者选择性 II-IV 区颈部淋巴结清扫术的淋巴结检出数和淋巴结密度。
Eur Arch Otorhinolaryngol. 2019 Oct;276(10):2923-2927. doi: 10.1007/s00405-019-05560-z. Epub 2019 Jul 17.
10
Epidemiology of gastric cancer: global trends, risk factors and prevention.胃癌流行病学:全球趋势、风险因素与预防
Prz Gastroenterol. 2019;14(1):26-38. doi: 10.5114/pg.2018.80001. Epub 2018 Nov 28.